355 related articles for article (PubMed ID: 29555831)
1. Diagnostic Accuracy of Biomarkers and Imaging for Bone Turnover in Renal Osteodystrophy.
Salam S; Gallagher O; Gossiel F; Paggiosi M; Khwaja A; Eastell R
J Am Soc Nephrol; 2018 May; 29(5):1557-1565. PubMed ID: 29555831
[No Abstract] [Full Text] [Related]
2. Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.
Sprague SM; Bellorin-Font E; Jorgetti V; Carvalho AB; Malluche HH; Ferreira A; D'Haese PC; Drüeke TB; Du H; Manley T; Rojas E; Moe SM
Am J Kidney Dis; 2016 Apr; 67(4):559-66. PubMed ID: 26321176
[TBL] [Abstract][Full Text] [Related]
3. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.
Haarhaus M; Monier-Faugere MC; Magnusson P; Malluche HH
Am J Kidney Dis; 2015 Jul; 66(1):99-105. PubMed ID: 25843703
[TBL] [Abstract][Full Text] [Related]
4. Circulating markers of bone turnover.
Vervloet MG; Brandenburg VM;
J Nephrol; 2017 Oct; 30(5):663-670. PubMed ID: 28502032
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Accuracy of Noninvasive Bone Turnover Markers in Renal Osteodystrophy.
Jørgensen HS; Behets G; Viaene L; Bammens B; Claes K; Meijers B; Naesens M; Sprangers B; Kuypers D; Cavalier E; D'Haese P; Evenepoel P
Am J Kidney Dis; 2022 May; 79(5):667-676.e1. PubMed ID: 34710517
[TBL] [Abstract][Full Text] [Related]
6. Relationship between plasma levels of sclerostin, calcium-phosphate disturbances, established markers of bone turnover, and inflammation in haemodialysis patients.
Pietrzyk B; Wyskida K; Ficek J; Kolonko A; Ficek R; Więcek A; Olszanecka-Glinianowicz M; Chudek J
Int Urol Nephrol; 2019 Mar; 51(3):519-526. PubMed ID: 30584645
[TBL] [Abstract][Full Text] [Related]
7. Biological markers in the diagnosis of the different forms of renal osteodystrophy.
Ferreira A; Drüeke TB
Am J Med Sci; 2000 Aug; 320(2):85-9. PubMed ID: 10981481
[TBL] [Abstract][Full Text] [Related]
8. Bone Biopsy Results in Chronic Kidney Disease: a Single-Center Experience.
Liangos O; Kirchhoff S; Buchholz J; Ketteler M
Kidney Blood Press Res; 2018; 43(4):1222-1230. PubMed ID: 30071519
[TBL] [Abstract][Full Text] [Related]
9. Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities.
Marques ID; Araújo MJ; Graciolli FG; Reis LM; Pereira RM; Custódio MR; Jorgetti V; Elias RM; David-Neto E; Moysés RM
Osteoporos Int; 2017 May; 28(5):1675-1683. PubMed ID: 28204954
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic accuracy study comparing total alkaline phosphatase with intact parathyroid hormone 1-84 for the diagnosis of high turnover renal osteodystrophy in chronic renal failure on hemodialysis].
Rojas González AM; Opazo Valenzuela M; Muñoz Navarro S
Medwave; 2014 Sep; 14(8):e6014. PubMed ID: 25340338
[TBL] [Abstract][Full Text] [Related]
11. Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney disease Stages 3 - 5.
Lehmann G; Ott U; Kaemmerer D; Schuetze J; Wolf G
Clin Nephrol; 2008 Oct; 70(4):296-305. PubMed ID: 18826854
[TBL] [Abstract][Full Text] [Related]
12. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
Bielesz BO; Hecking M; Plischke M; Cejka D; Kieweg H; Haas M; Marculescu R; Hörl WH; Bieglmayer C; Sunder-Plassmann G
Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265
[TBL] [Abstract][Full Text] [Related]
13. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children.
Baskin E; Beşbaş N; Saatçi U; Hasçelik G; Topaloğlu R; Ozen S; Bakkaloğlu A
Turk J Pediatr; 2004; 46(1):28-31. PubMed ID: 15074371
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
[TBL] [Abstract][Full Text] [Related]
15. Effects of parathyroidectomy on blood bone markers and heart rate variability in patients with stage 5 chronic kidney disease.
Chen H; Cui Y; Xing C; Purrunsing Y; Zha X; Shen C; Zeng M; Yang G; Yu X; Zhang L; Jiang Y; Shen Z; Ma H; Yin C; Li Y; Wang N
Int Urol Nephrol; 2018 Dec; 50(12):2279-2288. PubMed ID: 30361964
[TBL] [Abstract][Full Text] [Related]
16. Bone turnover markers predict type of bone histomorphometry and bone mineral density in Asian chronic haemodialysis patients.
Laowalert S; Khotavivattana T; Wattanachanya L; Luangjarmekorn P; Udomkarnjananun S; Katavetin P; Eiam-Ong S; Praditpornsilpa K; Susantitaphong P
Nephrology (Carlton); 2020 Feb; 25(2):163-171. PubMed ID: 30980579
[TBL] [Abstract][Full Text] [Related]
17. News on biomarkers in CKD-MBD.
Mazzaferro S; Tartaglione L; Rotondi S; Bover J; Goldsmith D; Pasquali M
Semin Nephrol; 2014 Nov; 34(6):598-611. PubMed ID: 25498379
[TBL] [Abstract][Full Text] [Related]
18. The five most commonly used intact parathyroid hormone assays are useful for screening but not for diagnosing bone turnover abnormalities in CKD-5 patients.
Herberth J; Monier-Faugere MC; Mawad HW; Branscum AJ; Herberth Z; Wang G; Cantor T; Malluche HH
Clin Nephrol; 2009 Jul; 72(1):5-14. PubMed ID: 19640382
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density: serum markers of bone turnover and their relationships in peritoneal dialysis.
Negri AL; Barone R; Quiroga MA; Bravo M; Marino A; Fradinger E; Bogado CE; Zanchetta JR
Perit Dial Int; 2004; 24(2):163-8. PubMed ID: 15119637
[TBL] [Abstract][Full Text] [Related]
20. Biochemical parameters of bone turnover in kidney transplant recipients.
Smalcelj R; Kusec V; Puretić Z; Mareković Z
Wien Klin Wochenschr; 1998 May; 110(9):326-30. PubMed ID: 9629624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
